Skip to content
Review

Epigenetic regulation of tubular epithelial cell dysfunction in diabetic kidney disease.

Aug 2026 · International Urology and Nephrology · 0 citations · 49 references
Medicine

TL;DR

In general, epigenetic regulation provides a new conceptual framework for understanding TEC dysfunction in DKD and provides a potential direction for the development of precision therapeutic strategies.

View source

Similar papers

Review Open access Jul 2026

Bidirectional regulation between mitochondrial metabolic reprogramming and epigenetic modifications in renal tubular epithelial cell injury of diabetic kidney disease

A narrative review elaborates the closed-loop crosstalk between mitochondrial metabolism and epigenetics in tubular injury, highlights the therapeutic prospect of targeting this bidirectional regulatory axis, and provides novel theoretical evidence for revealing DKD pathogenesis and developing targeted intervention reg...

Guijun Wu, Fanghong Chen, Qing Xiong · 0 citations
Review Open access Aug 2026

Natural products modulate renal metabolic reprogramming in diabetic kidney disease

This review systematically examines the mechanisms of metabolic reprogramming in different renal cell types and highlights their contribution to renal injury, highlighting the ability of natural products to confer renal protection by modulating key regulatory nodes of metabolic reprogramming.

Wenru Wang, Han Zhu, Keqin Zhao et al. · 0 citations
Review Open access Jul 2026

Metabolic Reprogramming and Immunometabolic Dysregulation in Diabetic Kidney Disease: From Pathogenesis to Precision Multi-target Therapies

Multi-omics integration and spatial transcriptomics hold promise for individualized and mechanism-guided interventions to halt diabetic kidney disease progression and propose precision strategies targeting mitochondrial homeostasis, ferroptosis inhibition, glycolytic blockade in immune cells, and multimodal therapies.

Zi-Yue Zhang, Yilun Qu, Xiaocheng Wang et al. · 0 citations
Review Jul 2026

Cellular Senescence in Diabetic Cardiomyopathy: Mechanistic Insights and Therapeutic Perspectives.

This review integrates current insights into the complex interplay among metabolic stress, mitochondrial injury, and cellular senescence in Diabetic cardiomyopathy and highlights promising directions for mechanism-based interventions aimed at combating diabetic cardiac remodeling.

Ting Ye, Dong-Lin Yang, Xinrui Chang et al. · 0 citations
Review Jul 2026

Endothelial-to-Mesenchymal Transition in Chronic Kidney Disease: Mechanisms and Therapeutic Targets.

The cellular and molecular mechanisms of EndMT relevant to CKD are summarized, key regulatory pathways and pathway crosstalk are highlighted, and emerging pharmacological approaches to limit EndMT, preserve microvascular integrity, and attenuate renal fibrogenesis are discussed.

Abdul Khan, Pratheesh D. Mankuzhy, L. Thomas et al. · 0 citations
Review Open access Aug 2026

Epigenetic Regulation of Liver Fibrosis: Mechanisms and Therapeutic Implications

This review summarizes the principal epigenetic changes involved in HSC activation, initiation/progression of liver fibrosis, and discusses recent interventions designed to modulate these epigenetic changes.

M. J. Tavaf, M. E. Varkiani, Saeid Abroun et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.